摘要
The present invention relates to a dengue vaccine, a pharmaceutical composition comprising the same, a nucleotide sequence, and an antibody composition. The dengue vaccine of the present invention includes chimeric nonstructural protein 1, which comprises N-terminus of DV NS1 from amino-acid residues 1 to 270 and C-terminus of JEV NS1 from amino-acid residues 271 to 352 (designated DJ NS1).
| 貢獻的翻譯標題 | 登革疫苗、包含該登革疫苗之醫藥組合物、核?酸序列、以及抗體組成物 |
|---|---|
| 原文 | English |
| 專利號 | 2428221 |
| 出版狀態 | Published - 1800 |
UN SDG
此研究成果有助於以下永續發展目標
